Stock Price
2.98
Daily Change
0.06 2.05%
Monthly
2.41%
Yearly
-10.51%
Q1 Forecast
3.02

Bioline Rx reported $84K in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Bioline Rx USD 84K 12K Sep/2025